Botulinum neurotoxin (BoNT), produced by , cleaves proteins involved in neurotransmitter release, thereby triggering flaccid paralyses, which are responsible for botulism. BoNT is classified into seven serotypes (BoNT/A-G); BoNT/A and BoNT/B are used as medical therapeutics and anti-wrinkle reagents. In this study, we investigated the efficacy of BoNT/CD, a mosaic toxin of BoNT/C and BoNT/D, to assess its potential as a therapeutic alternative for BoNT/A. In a cultured neuron assay, BoNT/CD cleaved syntaxin and SNAP-25 with higher efficacy than BoNT/C and BoNT/A. Intramuscularly administrated BoNT/CD induced dose-dependent muscle paralysis, and the paralysis lasted ~21 days in a mouse digit abduction score assay (BoNT/A-induced paralysis lasted ~30 days). BoNT/C failed to induce local paralysis without systemic toxicity. Multiple alignment analyses of the amino acid sequences of the receptor binding domain (H) of eight BoNT/CDs and two BoNT/Ds showed sequence clustering in five groups. Comparing BoNT/CD strain 003-9 (BoNT/CD) and strain 6813 (BoNT/CD) showed that both BoNT/CDs displayed similar efficacies in cultured neurons, but BoNT/CD displayed higher efficacy in a mouse model than BoNT/CD. These findings suggest that BoNT/CD may be a potential alternative for patients who do not respond to existing BoNT-based therapeutics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962336 | PMC |
| http://dx.doi.org/10.3390/toxins15020123 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of Serotype CD Mosaic Botulinum Neurotoxin in Comparison with Serotype C and A.
Toxins (Basel)
February 2023
Department of Food, Aroma and Cosmetic Chemistry, Faculty of Bioindustry, Tokyo University of Agriculture, Abashiri 099-2493, Hokkaido, Japan.
Botulinum neurotoxin (BoNT), produced by , cleaves proteins involved in neurotransmitter release, thereby triggering flaccid paralyses, which are responsible for botulism. BoNT is classified into seven serotypes (BoNT/A-G); BoNT/A and BoNT/B are used as medical therapeutics and anti-wrinkle reagents. In this study, we investigated the efficacy of BoNT/CD, a mosaic toxin of BoNT/C and BoNT/D, to assess its potential as a therapeutic alternative for BoNT/A.
View Article and Find Full Text PDFA Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
Toxins (Basel)
September 2021
Department of Anesthesia & Perioperative Care, University of California, San Francisco, Zuckerberg San Francisco General Hospital and Trauma Center, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
Article Synopsis
- Human botulism is caused by different serotypes of botulinum neurotoxin (BoNT) and this study focused on developing an antitoxin using four human monoclonal antibodies (mAbs) targeting BoNT/C, BoNT/D, and their mosaic toxins.
- The mAbs were created from human immune libraries and showed strong binding to multiple serotypes, with three undergoing evolution to enhance their affinity.
- A combination of these mAbs demonstrated effective neutralization and has potential for therapeutic and diagnostic applications, with one derivative (NTM-1634) showing safety in a Phase 1 clinical trial.
Detection of Active BoNT/C and D by EndoPep-MS Using MALDI Biotyper Instrument and Comparison with the Mouse Test Bioassay.
Toxins (Basel)
December 2020
Special Bacteriology Laboratory, SCT2-Istituto Zooprofilattico Sperimentale delle Venezie, Vicolo Mazzini 4, 31020 Fontane di Villorba (TV), Italy.
Botulinum neurotoxins (BoNTs) are among the most poisonous known biological substances, and therefore the availability of reliable, easy-to use tools for BoNT detection are important goals for food safety and human and animal health. The reference method for toxin detection and identification is the mouse bioassay (MBA). An EndoPep-MS method for BoNT differentiation has been developed based on mass spectrometry.
View Article and Find Full Text PDFPublic Health Risk Associated with Botulism as Foodborne Zoonoses.
Toxins (Basel)
December 2019
Institut Pasteur, Département de Microbiologie, Unité des Toxines Bactériennes, 25 rue du Dr Roux, 75015 Paris, France.
Botulism is a rare but severe neurological disease in man and animals that is caused by botulinum neurotoxins (BoNTs) produced by and atypical strains from other and non- species. BoNTs are divided into more than seven toxinotypes based on neutralization with specific corresponding antisera, and each toxinotype is subdivided into subtypes according to amino acid sequence variations. Animal species show variable sensitivity to the different BoNT toxinotypes.
View Article and Find Full Text PDFStructural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.
Biochimie
July 2013
Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Botulinum neurotoxin (BoNT), the causative agent of the deadly neuroparalytic disease botulism, is the most poisonous protein known for humans. Produced by different strains of the anaerobic bacterium Clostridium botulinum, BoNT effects cellular intoxication via a multistep mechanism executed by the three modules of the activated protein. Endocytosis, the first step of cellular intoxication, is triggered by the ~50 kDa, heavy-chain receptor-binding domain (HCR) that is specific for a ganglioside and a protein receptor on neuronal cell surfaces.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!